Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SETDB1 encodes a histone methyltransferase which regulates histone methylation, gene silencing, and transcriptional repression. Additionally we are shipping SETDB1 Proteins (7) and many more products for this protein.
Showing 10 out of 114 products:
Human Monoclonal SETDB1 Primary Antibody for IF, WB - ABIN394317
Mavaddat, Dunning, Ponder, Easton, Pharoah: Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009
Show all 5 references for 394317
Human Polyclonal SETDB1 Primary Antibody for EIA, WB - ABIN356608
Maclean: The Action of Muscarin and Pilocarpin on the Hearts of Certain Vertebrates, with Observations on Seasonal Changes. in The Biochemical journal 2006
Show all 5 references for 356608
Human Polyclonal SETDB1 Primary Antibody for WB - ABIN387924
Ichimura, Watanabe, Sakamoto, Aoto, Fujita, Nakao: Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins. in The Journal of biological chemistry 2005
Show all 4 references for 387924
Human Polyclonal SETDB1 Primary Antibody for ELISA, IHC - ABIN4353068
Schultz, Ayyanathan, Negorev, Maul, Rauscher: SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. in Genes & development 2002
Show all 3 references for 4353068
Human Polyclonal SETDB1 Primary Antibody for ICC, IF - ABIN4353070
Ceol, Houvras, Jane-Valbuena, Bilodeau, Orlando, Battisti, Fritsch, Lin, Hollmann, Ferré, Bourque, Burke, Turner, Uong, Johnson, Beroukhim, Mermel, Loda, Ait-Si-Ali, Garraway, Young, Zon: The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. in Nature 2011
Show all 2 references for 4353070
Human Monoclonal SETDB1 Primary Antibody for ICC, ELISA - ABIN969394
Gevaert, Staes, Van Damme, De Groot, Hugelier, Demol, Martens, Goethals, Vandekerckhove: Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. in Proteomics 2005
Show all 2 references for 969394
Human Monoclonal SETDB1 Primary Antibody for ELISA, WB - ABIN969393
Rosendorff, Sakakibara, Lu, Kieff, Xuan, DiBacco, Shi, Shi, Gill: NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. in Proceedings of the National Academy of Sciences of the United States of America 2006
Show all 2 references for 969393
Human Polyclonal SETDB1 Primary Antibody for BP, ChIP - ABIN4353071
Skuland, Ovrevik, Låg, Schwarze, Refsnes: Silica nanoparticles induce cytokine responses in lung epithelial cells through activation of a p38/TACE/TGF-α/EGFR-pathway and NF-κΒ signalling. in Toxicology and applied pharmacology 2014
SETDB1 is essential for the earliest events in lineage specification in the bovine blastocyst.
SETDB1, a major histone H3K9 methyltransferase is monoubiquitinated at the evolutionarily conserved lysine-867 in its SET-Insertion domain. This ubiquitination is directly catalyzed by UBE2E family of E2 enzymes in an E3-independent manner while the conjugated-ubiquitin (Ub) is protected from active deubiquitination.
These results suggest that the ubiquitination of SETDB1 at lysine 867 controls the expression of its target gene by activating its H3K9 methyltransferase activity.
Authors observed several complementary mechanisms contributing to the upregulation of SETDB1 in HCC (show FAM126A Antibodies) cells. Besides copy number gains at the SETDB1 gene locus at chromosome 1q21 enhanced SETDB1 transcription mediated by the transcription factor SP1 (show SP1 Antibodies) could be detected.
BRCA1 and SETDB1 stand out as the most significant prognostic markers in this group of patients
These results suggest that SETDB1- mediated FosB (show FOSB Antibodies) expression is a common molecular phenomenon, and might be a novel pathway responsible for the increase in cell proliferation that frequently occurs during anticancer drug therapy.
SETDB1 mutations are associated with malignant pleural mesotheliomas.
Upon HBV infection, cellular mechanisms involving SETDB1-mediated H3K9me3 and HP1 (show DEFA1 Antibodies) induce silencing of HBV cccDNA transcription through modulation of chromatin structure.
The SETDB1 protein was closely associated with the prognosis of prostate cancer (PCa (show FLVCR1 Antibodies)). Bioinformatics suggested that SETDB1 might promote PCa (show FLVCR1 Antibodies) bone metastasis through the WNT (show WNT2 Antibodies) pathway. In conclusion, SETDB1 might be associated with the development of bone metastases from PCa (show FLVCR1 Antibodies)
results indicate that ATF7IP (show ATF7IP Antibodies) does not directly modulate SETDB1 catalytic activity, suggesting alternate roles, such as affecting cellular localization or mediating interaction with additional binding partners.
SETDB1 is an oncogene (show RAB1A Antibodies) that is frequently up-regulated in human HCCs (show HCCS Antibodies); the multiplicity of SETDB1 activating mechanisms at the chromosomal, transcriptional, and posttranscriptional levels together facilitates SETDB1 up-regulation in human HCC (show FAM126A Antibodies)
study identifed ESET as first trimethylated H3K9 histone methyltransferase playing a crucial role in T cell development
Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes.
SETDB1 maintains silencing of intracisternal A particle, but in the absence of DNMT1 (show DNMT1 Antibodies), prolonged binding of NP95 (show UHRF1 Antibodies) to hemimethylated DNA transiently disrupts SETDB1-dependent H3K9me3 deposition.
Deletion of Setdb1 led to enlarged Meckel's cartilage. Chondrocytes from the Meckel's cartilage of Setdb1 mutant showed increased in size.
Setdb1 is a maternal-effect (show NLRP5 Antibodies) gene that controls meiotic progression and is essential for early embryogenesis. Setdb1 is an important regulator of Cdc14b (show CDC14B Antibodies).
The currently identified reciprocal action between SETDB1 and PRC2 reveals a novel mechanism underlying ES cell pluripotency and differentiation regulation.
regulates cancer cell growth via methylation of p53 (show TP53 Antibodies)
Data show that histone methyltransferase SETDB1 functions as an epigenetic repressor of all endogenous retroviruses (ERVs) in B lymphocytes.
these findings reveal a novel regulatory hierarchy governing SETDB1 recruitment and in turn, transcriptional silencing in mESCs.
This gene encodes a histone methyltransferase which regulates histone methylation, gene silencing, and transcriptional repression. This gene has been identified as a target for treatment in Huntington Disease, given that gene silencing and transcription dysfunction likely play a role in the disease pathogenesis. Alternatively spliced transcript variants of this gene have been described.
histone-lysine N-methyltransferase SETDB1
, SET domain, bifurcated 1
, histone-lysine N-methyltransferase SETDB1-like
, histone-lysine N-methyltransferase SETDB1-A
, ERG-associated protein with SET domain
, ERG-associated protein with a SET domain, ESET
, H3-K9-HMTase 4
, histone H3-K9 methyltransferase 4
, histone-lysine N-methyltransferase, H3lysine-9 specific 4
, lysine N-methyltransferase 1E
, tudor domain containing 21
, SET domain ERG-associated histone methyltransferase